FOLH1 and prostate carcinoma: PSMA is a type-II integral membrane protein capable of activating the NF-κB transcription factor [88], predominantly localized to the epithelial cells of the prostate gland and whose expression increases several fold in high-grade prostate cancers and in metastatic and in androgen-insensitive prostate carcinoma [88].